Anebulo Pharmaceuticals Inc (ANEB)
NASDAQ
The current ANEB market cap is 37.08M. The company's latest EPS is USD -0.3163 and P/E is -4.52.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.49M | -2.54M | -2.76M | -1.66M | -1.34M |
Net Income | -2.5M | -2.48M | -2.72M | -1.65M | -1.35M |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -174k | -3.61M | -6.83M | -11.78M | -8.31M |
Net Income | -175k | -38.46M | -6.83M | -11.73M | -8.2M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 11.67M | 9.05M | 7.5M | 6M | 4.07M |
Total Liabilities | 1.07M | 717k | 1.01M | 1.01M | 260k |
Total Equity | 10.6M | 8.33M | 6.49M | 4.99M | 3.81M |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.03M | 21.65M | 15.58M | 11.67M | 4.07M |
Total Liabilities | 224k | 242k | 513k | 1.07M | 260k |
Total Equity | -171k | 21.41M | 15.07M | 10.6M | 3.81M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -9.68M | -2.73M | -4.54M | -6.04M | -8.09M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 6.38M | N/A | -62k | -62k | -62k |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -151k | -4.87M | -5.44M | -9.68M | -8.09M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 3.18M | 21.83M | N/A | 6.38M | -62k |
Market Cap | 37.08M |
Price to Earnings Ratio | -4.52 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 11.99 |
Price to Book Ratio | 9.73 |
Dividend Yield | - |
Shares Outstanding | 25.93M |
Average Volume (1 week) | 8.13k |
Average Volume (1 Month) | 6.79k |
52 Week Change | -37.55% |
52 Week High | 3.30 |
52 Week Low | 1.25 |
Spread (Intraday) | 0.32 (19.75%) |
Company Name | Anebulo Pharmaceuticals Inc |
Address |
838 walker road dover, delaware 19904 |
Website | https://www.anebulo.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.